Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00446.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Blythe D Shepard und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Science, Georgetown University, Washington, District of Columbia, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Sodium-Glucose Transporter 2 Inhibitors, Kidney Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Renal protection afforded by sodium glucose transporter, type 2 inhibitors (SGLT2i), e.g., empagliflozin (EMPA) involves complex intertwined mechanisms. Using a novel mouse model of obesity with insulin resistance, the TallyHo/Jng (TH) mouse on a high-milk-fat diet (HMFD), we found subtle changes in metabolism including altered regulation of sodium transporters that line the renal tubule. New potential epigenetic determinants of metabolic changes relating to FOXO and cancer signaling pathways were elucidated from an altered urine exosomal microRNA signature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Science, Georgetown University, Washington, District of Columbia, United States.
- Department of Medicine,Georgetown University, Washington, District of Columbia, United States.
- Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States.
- J Crayton Pruitt Department of Biomedical Engineering, University of Florida, Gainesville, Florida, United States.
- Department of Computational Cell Biology, Anatomy, and Pathology, State University of New York at Buffalo, Buffalo, New York, United States.
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States.
ORCID-Profile: Blythe D Shepard, Aline M A De Souza, Moshe Levi, Carolyn M Ecelbarger
Förderung
- American Heart Association-American Stroke Association
- NIDDK NIH HHS
- NCATS NIH HHS
- NCI NIH HHS
- NIH HHS
- Dekkers Endowed Chair in Human Science
- American Heart Association
- HHS | NIH | National Cancer Institute
Zitieren
APA
Shepard, B. D., Chau, J., Kurtz, R., Rosenberg, A. Z., Sarder, P., Border, S. P., Ginley, B., Rodriguez, O., Albanese, C., Knoer, G., Greene, A., De Souza, A. M. A., Ranjit, S., Levi, M., & Ecelbarger, C. M. (2024). Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00446.2023
Vancouver
Shepard BD, Chau J, Kurtz R, Rosenberg AZ, Sarder P, Border SP, et al. Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00446.2023
BibTeX
@article{Shepard2024,
author = {Shepard, Blythe D and Chau, Jennifer and Kurtz, Ryan and Rosenberg, Avi Z and Sarder, Pinaki and Border, Samuel P and Ginley, Brandon and Rodriguez, Olga and Albanese, Chris and Knoer, Grace and Greene, Aarenee and De Souza, Aline M A and Ranjit, Suman and Levi, Moshe and Ecelbarger, Carolyn M},
title = {Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00446.2023}
}
EUVIMED